Roderick De Greef
CIK 1241181 · Chief Executive Officer · last filed 2026-10-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BLFS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) Delisted | Chief Executive Officer | 439,774 | $38.61 | $16.98M | -$21.97M | 84 | 2026-10-08 |
| PARETEUM Corp (TEUM) Delisted | Director | 18,078 | — | — | $30.4K | 2 | 2017-02-24 |
| PARETEUM Corp (ETAK) Delisted | Director | 176,038 | — | — | $0 | 2 | 2016-04-29 |
| ENDOLOGIX INC /DE/ (ELGX) Delisted | Director | 860 | — | — | -$2.31M | 12 | 2013-03-08 |
Recent Filings · Page 5 of 13
121 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-12-30 | BIOLIFE SOLUTIONS INC (BLFS) Delisted | Sell (S) | −705 | -$27.8K | EDGAR |
| 2021-11-18 | BIOLIFE SOLUTIONS INC (BLFS) Delisted | Sell (S) | −21,000 | -$1.07M | EDGAR |
| 2021-10-27 | BIOLIFE SOLUTIONS INC (BLFS) Delisted | Sell (S) | −2,371 | -$105.8K | EDGAR |
| 2021-10-18 | BIOLIFE SOLUTIONS INC (BLFS) Delisted | Sell (S) | −1,221 | -$48.8K | EDGAR |
| 2021-09-30 | BIOLIFE SOLUTIONS INC (BLFS) Delisted | Sell (S) | −689 | -$29.7K | EDGAR |
| 2021-08-19 | BIOLIFE SOLUTIONS INC (BLFS) Delisted | Sell (S) | −46,239 | -$2.07M | EDGAR |
| 2021-07-01 | BIOLIFE SOLUTIONS INC (BLFS) Delisted | Sell (S) | −685 | -$30.0K | EDGAR |
| 2021-04-15 | BIOLIFE SOLUTIONS INC (BLFS) Delisted | Mixed | −10,000 | -$702.1K | EDGAR |
| 2021-04-14 | BIOLIFE SOLUTIONS INC (BLFS) Delisted | Grant (A) | +3,222 | $0 | EDGAR |
| 2021-04-05 | BIOLIFE SOLUTIONS INC (BLFS) Delisted | Mixed | +6,077 | -$140.8K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).